Insider Holders & Insider Ownership - LEXICON PHARMACEUTICALS INC. (LXRX)

List of insiders holdings for LEXICON PHARMACEUTICALS INC.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
#Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
1Artal International S.C.A.
Wittouck Amaury
Artal International Management S.A.
Artal Group S.A.
Westend S.A.
Stichting Administratiekantoor Westend
Invus Public Equities L.P.
Invus L.P.
Invus Public Equities Advisors LLC
Invus Advisors L.L.C.
Director
10% Owner
2024-12-09 21:33:20136,180,481
0
136,180,481Form 13D
2Artal Participations S.a r.l.
Director
10% Owner
2024-12-16 19:00:08136,180,481
0
136,180,481Form 3
3Invus Public Equities L.P.
Artal Treasury Ltd
Invus L.P.
Invus Public Equities Advisors LLC
Invus Advisors L.L.C.
Director
10% Owner
2024-12-09 21:33:20136,180,481
0
136,180,481Form 13D
4Artal International S.C.A.
Minne Pascal
Artal International Management S.A.
Artal Group S.A.
Westend S.A.
Stichting Administratiekantoor Westend
Director
10% Owner
2020-12-17 14:43:180
71,178,364
71,178,364Form 4
5Siren L.L.C.
Invus Global Management LLC
Director
10% Owner
2024-07-29 17:31:420
38,918,903
38,918,903Form 3
6MCNAIR ROBERT C
10% Owner
2003-08-08 16:21:095,949,400
0
5,949,400Form 13D
7Invus US Partners LLC
Ulys L.L.C.
DEBBANE RAYMOND
Director
10% Owner
2022-08-09 16:48:13331,545
5,451,204
5,782,749Form 4
8Invus C.V.
Director
10% Owner
2021-01-05 21:21:124,321,214
0
4,321,214Form 4
9Exton Michael
Chief Executive Officer
2025-02-18 16:16:423,774,480
0
3,774,480Form 4
10SANDS ARTHUR T
President & CEO
2014-03-03 18:20:201,236,579
877,500
2,114,079Form 4
11COATS LONNEL
Chief Executive Officer
2024-02-29 16:26:531,430,198
0
1,430,198Form 4
12Coiante Scott M
SVP, Chief Financial Officer
2025-02-18 16:17:541,201,780
0
1,201,780Form 4
13Corrigan Brian
SVP, Regulatory & QA
2025-02-18 16:18:381,121,660
0
1,121,660Form 4
14Gopinathan Suma
SVP, Discovery
2025-06-09 10:03:46637,980
0
637,980Form 3
15Martens Rachel Yap
VP, Partnerships & Corp Strat
2025-06-06 17:40:27553,346
0
553,346Form 3
16MAIN ALAN J
EVP, Innov & Chem Sciences
2025-03-03 16:32:25508,494
0
508,494Form 4
17Garner Thomas
SVP, Chief Commercial Officer
2024-02-12 16:14:04454,260
0
454,260Form 4
18Crum Brian T
SVP, General Counsel & Secr.
2025-03-03 16:28:42433,045
0
433,045Form 4
19ZAMBROWICZ BRIAN P
EVP, Chief Scientific Officer
2014-03-03 18:16:40402,953
0
402,953Form 4
20WADE JEFFREY L
President and COO
2024-07-08 17:27:46307,000
0
307,000Form 4
21Granowitz Craig B
SVP, Chief Medical Officer
2025-03-03 16:31:11304,495
0
304,495Form 4
22Kassler-Taub Kenneth B.
SVP, Regulatory & QA
2024-02-29 16:29:48255,742
0
255,742Form 4
23McDermott Wendy
SVP, Human Resources
2025-03-03 16:33:08253,976
0
253,976Form 4
24BROWN PHILIP M
SVP, Clinical Development
2010-02-17 17:12:29253,606
0
253,606Form 4
25BANSAL AJAY
EVP Corp Dev and CFO
2009-06-02 17:44:48250,000
0
250,000Form 4
26TYLE PRAVEEN
EVP, R&D
2021-03-02 17:00:45204,771
0
204,771Form 4
27BARKER SAM L
Director
2025-06-03 16:22:03193,118
0
193,118Form 4
28Cheung Ivan
Director
2025-06-03 16:22:40193,118
0
193,118Form 4
29SOBECKI CHRISTOPHER J
Director
2025-06-03 16:23:33193,118
0
193,118Form 4
30Sullivan Diane E.
Director
2025-06-03 16:24:21193,118
0
193,118Form 4
31Amouyal Philippe
Director
2025-06-03 16:21:00193,118
0
193,118Form 4
32DEBBANE RAYMOND
Director
2025-06-03 16:20:14193,118
0
193,118Form 4
33Swain Judith L
Director
2025-06-03 16:25:29193,118
0
193,118Form 4
34RIGGS RANDALL B
SVP, Corp Licensing
2004-02-25 16:13:19192,500
0
192,500Form 4
35GREGORY JULIA P
EVP and CFO
2008-02-11 18:05:27150,000
0
150,000Form 4
36Alexander Kristen
VP, Finance and Accounting
2025-03-03 16:33:57132,068
0
132,068Form 4
37Tessmer James F
VP, Finance & Accounting
2021-03-16 19:45:56122,746
0
122,746Form 4
38Seth Kiernan
VP, Chief Commercial Officer
2023-03-01 16:55:29104,350
0
104,350Form 4
39HOWSON TAMAR D
EVP of Bus Dev
2008-02-11 18:05:30100,000
0
100,000Form 4
40Lapuerta Pablo
EVP and CMO
2020-04-24 17:02:5785,719
0
85,719Form 4
41Tragash Steven Alan
VP, Corporate Affairs
2010-02-17 18:06:1785,500
0
85,500Form 4
42LEFKOWITZ ROBERT J MD
Director
2024-05-13 16:03:0881,716
0
81,716Form 4
43ISHIMOTO LANCE K
SVP, Intellectual Property
2008-02-11 18:05:3380,000
0
80,000Form 4
44PERSON CHRISTOPHE
VP Informatics
2004-01-13 17:01:4875,900
0
75,900Form 4
45DeFrancesco Lisa
SVP, IR and Corp Comm
2025-03-03 16:30:2464,924
0
64,924Form 4
46SCHAFER CAROL
VP Finance - Communications
2003-12-10 15:01:4661,000
0
61,000Form 3
47Santini Alexander A
EVP and CCO
2020-04-24 17:12:2255,584
0
55,584Form 4
48PIGGOTT JAMES R PHD
SVP of Pharm Bio
2008-02-11 18:05:4050,000
0
50,000Form 4
49NORTHCOTT JOHN
VP, Marketing, Comm Strategy
2015-03-03 16:08:1441,985
0
41,985Form 4
50NIES ALAN S
Director
2023-05-22 16:05:2041,046
0
41,046Form 4
51Palantoni Frank
Director
2023-05-22 16:06:0740,332
0
40,332Form 4
52COLBERT WALTER F
SVP, HR and Corp Serv
2007-02-15 16:40:1340,000
0
40,000Form 4
53ROSE CLAYTON STUART
Director
2007-06-27 16:34:1325,000
0
25,000Form 4
54Wiltsey Kathleen M
Director
2009-04-27 16:40:2510,000
0
10,000Form 4
55Mills Barry
Director
2007-04-27 16:35:3810,000
0
10,000Form 4
56CLOHERTY PATRICIA M
Director
2006-04-28 17:58:2710,000
0
10,000Form 4
57CASKEY C THOMAS
Director
2005-10-17 17:52:096,300
200
6,500Form 4